Kotecha RR, Motzer RJ, Voss MH (2019) Towards individualized therapy for metastatic renal cell carcinoma. Nat Rev Clin Oncol 16(10):621–633. https://doi.org/10.1038/s41571-019-0209-1

Article  CAS  PubMed  Google Scholar 

Cullin N, Antunes A, Straussman C, Stein-Thoeringer R, C. K., Elinav E (2021) Microbiome and cancer. Cancer Cell 39(10):1317–1341. https://doi.org/10.1016/j.ccell.2021.08.006

Article  CAS  PubMed  Google Scholar 

Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, Jacks T (2019) Commensal microbiota promote lung cancer development via γδ T cells. Cell 176(5):998–1013e16. https://doi.org/10.1016/j.cell.2018.12.040

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pushalkar S, Hundeyin M, Daley D et al (2018) The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov 8(4):403–416. https://doi.org/10.1158/2159-8290.CD-17-1134

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song X, Li X (2021) Overview of microbial flora in breast cancer. Chin J Biomedical Eng 27(4):448–452. https://doi.org/10.3760/cma.j.cn115668-20210218-00027

Article  CAS  Google Scholar 

Nejman D, Livyatan I, Fuks G et al (2020) The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368(6494):973–980. https://doi.org/10.1126/science.aay9189

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, Miller G (2018) The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov 8(4):403–416. https://doi.org/10.1158/2159-8290.CD-17-1134

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jain T, Sharma P, Are AC, Vickers SM, Dudeja V (2021) New insights into the cancer-microbiome-immune axis: decrypting a decade of discoveries. Front Immunol 12:622064. https://doi.org/10.3389/fimmu.2021.622064

Article  CAS  PubMed  PubMed Central  Google Scholar 

Méndez-Vidal MJ, Lázaro Quintela M, Lainez-Milagro N, Perez-Valderrama B, Suárez Rodriguez C, Arija A, Peláez Fernández JÁ, Gallardo I, Díaz E, Lambea Sorrosal J, González-Del-Alba A (2023) SEOM SOGUG clinical guideline for treatment of kidney cancer (2022). Clin Transl Oncol 25(9):2732–2748. https://doi.org/10.1007/s12094-023-03276-5

Article  PubMed  PubMed Central  Google Scholar 

Bodard S, Dariane C, Bibault JE, Boudhabhay I, Delavaud C, Timsit MO, Verkarre V, Méjean A, Hélénon O, Guinebert S, Correas JM (2024) Épargne néphronique dans la prise en charge des tumeurs rénales malignes solides localisées [Nephron sparing in the management of localized solid renal mass]. Bull Cancer 111(7–8):720–732. https://doi.org/10.1016/j.bulcan.2023.04.005

Article  PubMed  Google Scholar 

Huang J, Leung DK, Chan EO, Lok V, Leung S, Wong I, Lao XQ, Zheng ZJ, Chiu PK, Ng CF, Wong JH, Volpe A, Merseburger AS, Powles T, Teoh JY, Wong MCS (2022) A global trend analysis of kidney cancer incidence and mortality and their associations with smoking, alcohol consumption, and metabolic syndrome. Eur Urol Focus 8(1):200–209. https://doi.org/10.1016/j.euf.2020.12.020

Article  PubMed  Google Scholar 

Huang JJ, Hsieh JJ (2020) The therapeutic landscape of renal cell carcinoma: from the dark age to the golden age. Semin Nephrol 40(1):28–41. https://doi.org/10.1016/j.semnephrol.2019.12.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scelo G, Larose TL (2018) Epidemiology and risk factors for kidney cancer. J Clin Oncol 36(36):JCO2018791905. https://doi.org/10.1200/JCO.2018.79.1905

Article  PubMed  Google Scholar 

Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L (2022) Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. Giornale Italiano Di Nefrologia 39(3):2022–vol3

PubMed  Google Scholar 

Gray RE, Harris GT (2019) Renal cell carcinoma: Diagnosis and management. American Family Physician, 99(3), 179–184. Erratum in: American Family Physician, 99(12), 732

Yan XQ, Ye MJ, Zou Q, Chen P, He ZS, Wu B, He DL, He CH, Xue XY, Ji ZG, Chen H, Zhang S, Liu YP, Zhang XD, Fu C, Xu DF, Qiu MX, Lv JJ, Huang J, Ren XB, Cheng Y, Qin WJ, Zhang X, Zhou FJ, Ma LL, Guo JM, Ding DG, Wei SZ, He Y, Guo HQ, Shi BK, Liu L, Liu F, Hu ZQ, Jin XM, Yang L, Zhu SX, Liu JH, Huang YH, Xu T, Liu B, Sun T, Wang ZJ, Jiang HW, Yu DX, Zhou AP, Jiang J, Luan GD, Jin CL, Xu J, Hu JX, Huang YR, Guo J, Zhai W, Sheng XN (2024) Toripalimab plus Axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study. Ann Oncol 35(2):190–199. https://doi.org/10.1016/j.annonc.2023.09.3108

Article  CAS  PubMed  Google Scholar 

Méjean A (2017) Progrès dans les traitements des cancers du rein [Advancement in the treatment of renal carcinoma]. Néphrologie Thérapeutique 13(3):154–159. https://doi.org/10.1016/j.nephro.2017.02.008

Article  PubMed  Google Scholar 

Chen VJ, Hernandez-Meza G, Agrawal P, Zhang CA, Xie L, Gong CL, Hoerner CR, Srinivas S, Oermann EK, Fan AC (2019) Time on therapy for at least three months correlates with overall survival in metastatic renal cell carcinoma. Cancers (Basel) 11(7):1000. https://doi.org/10.3390/cancers11071000

Article  CAS  PubMed  Google Scholar 

Liss MA, Chen Y, Rodriguez R, Pruthi D, Johnson-Pais T et al (2020) Microbiome within primary tumor tissue from renal cell carcinoma may be associated with PD-L1 expression of the venous tumor thrombus. Adv Urol, 2020:9068068. https://doi.org/10.1155/2020/9068068

Kovaleva OV, Podlesnaya P, Sorokin M, Mochalnikova V, Kataev V, Khlopko YA, Plotnikov AO, Stilidi IS, Kushlinskii NE, Gratchev A (2022) Macrophage phenotype in combination with tumor microbiome composition predicts RCC patients’ survival: a pilot study. Biomedicines 10(7):1516. https://doi.org/10.3390/biomedicines10071516

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heidler S, Lusuardi L, Madersbacher S, Freibauer C (2020) The microbiome in benign renal tissue and in renal cell carcinoma. Urol Int 104:247–252. https://doi.org/10.1159/000500190

Article  CAS  PubMed  Google Scholar 

Wang J, Li X, Wu X, Wang Z, Zhang C et al (2021) Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing. J Cancer Res Clin Oncol 147:481–491. https://doi.org/10.1007/s00432-020-03434-7

Article  CAS  PubMed  Google Scholar 

Helmink BA, Khan MAW, Hermann A et al (2019) The microbiome, cancer, and cancer therapy. Nat Med 25(3):377–388. https://doi.org/10.1038/s41591-019-0377-7

Article  CAS  PubMed  Google Scholar 

Schwabe RF, Jobin C (2013) The microbiome and cancer. Nat Rev Cancer 13(11):800–812. https://doi.org/10.1038/nrc3610

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Z, Shi C, Zheng JW et al (2021) Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma. BMC Microbiol 21:301. https://doi.org/10.1186/s12866-021-02314-5

Article  PubMed  PubMed Central  Google Scholar 

Fu A, Yao B, Dong T, Cai S (2023) Emerging roles of intratumor microbiota in cancer metastasis. Trends Cell Biol 33(7):583–593. https://doi.org/10.1016/j.tcb.2022.11.007

Article  CAS  PubMed  Google Scholar 

Parida S, Wu SG, Siddharth S et al (2021) A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and β-catenin axes. Cancer Discov 11(5):1138–1157. https://doi.org/10.1158/2159-8290.CD-20-1200

Article  CAS  PubMed  Google Scholar 

Ramírez-Labrada AG, Isla D, Artal A, Arias M, Rezusta A, Pardo J, Gálvez EM (2020) The influence of lung microbiota on lung carcinogenesis, immunity, and Immunotherapy. Trends Cancer 6(2):86–97. https://doi.org/10.1016/j.trecan.2019.12.007

Article  CAS  PubMed